Kazia Therapeutics KZIA
NASDAQ KZIA
$7.81 -0.26 (-3.22%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Gains from Investment Securities (2012 - 2023)

Updated

Kazia Therapeutics' Gains from Investment Securities came in at -$1.07 million for the year ended Jun 30, 2012, compared with $1.05 million a year earlier.

Analysis

Kazia Therapeutics (KZIA) Gains from Investment Securities (2012 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Gains from Investment Securities at $1.05 million in the year ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Kazia Therapeutics 351,450.00 -52.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -55,065.33
Dec 31, 2013 4.59 Mn
Aug 30, 2013 5.89 Mn
Dec 31, 2012 8.30 Mn
API Access

Kazia Therapeutics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=KZIA&period=max&api_key=YOUR_API_KEY